Skip to main content
Adjuvants vétérinaires prêts à l'emploi

b博金冠平台注册: MONTANIDE? Range

博金冠平台是否已经被警方打击 www.ofvo6.com.cn Ready-to-use veterinary adjuvants

Selecting the right adjuvant is one of the keys to success of a veterinary vaccine in the field. Safety and efficacy balance must be taken into account, as well as the animal species and its sensitivity, the antigen (inactivated or live), its type (viral, bacterial, parasite) and its nature (crude extract, purified, recombinant, peptide, DNA), the desired immune response kinetics (short or long-term) and its profile (humoral or cellular), and the administration route (injection, mucosal, mass vaccination). Since the 70's, SEPPIC has been combining expertise and service to develop MONTANIDE? adjuvants adapted to the veterinary needs.

MONTANIDE? range

To meet vaccine developers' needs and to improve efficacy and stability of veterinary vaccines, SEPPIC has developed a wide range of ready-to-use adjuvants based on 3?technologies: emulsions, micro-emulsions and polymers.

These veterinary adjuvants are manufactured under International Pharmaceutical Excipient Council (IPEC) manufacturing guidelines in SEPPIC manufacturing sites of Castres (France) and Qing Pu (China).

MONTANIDE? safety and regulatory status

Based on toxicological tests and field experience, MONTANIDE? adjuvants are considered as safe for veterinary applications such as vaccines.

MONTANIDE? adjuvants and their components have been approved by the Committee for Veterinary Medical Products (CVMP) for use in immunological products. Their components are either included in the Allowed Substances table of the Annex to European Council Regulation (EU) No?37/2010 as substances needing no further Maximum Residue Limits (MRL) studies, or considered as not falling within the scope of Regulation (EC) No?470/2009 when used in a veterinary product.

The properties of the antigenic medium are crucial for both vaccine efficacy and safety. Each team developing a vaccine has to study the safety and efficacy profile of the formula under development according to local market acceptance criteria.

Services around MONTANIDE?

Expertise and know how
Bibliographic searches, vaccination protocols, efficacy screening on mice

Formulation studies
Selection among pharmaceutical technologies (emulsion, polymer, solid form, etc.)

Selection of samples
Adapted to the model of the customer for vaccine stability and performance

Scale-up assistance
From the laboratory to small and large scale industrial production

Customized formulation
For specific antigens, delivery systems, new concepts

Training & worshops
Vaccine formulation, laboratory and pilot processes, quality control of adjuvants and vaccines

Regulatory affairs support
For vaccine registration, customs, etc.

  • 为祝贺你们!为你们自豪,为你们骄傲——中国核电的创新者!这是“两弹一星”精神的延续,是“两弹一星”精神的发扬!有良心的中国人,更要感谢以毛泽东为首的老一辈无产阶 2018-12-13
  • 法制日报:文保追责终身制重在落地 2018-12-12
  • 既然主贴跟帖都不给发 那我就让管理彻底一边倒去吧,我也彻底休息了。 2018-12-11
  • The GNU General Public License v3.0 2018-12-11
  • 德州齐河司法所开展人民调解“回头看”工作 2018-12-10
  • 江西“安全生产月”宣传咨询日活动启动 2018-12-09
  • 端午小长假自驾游归来 车辆保养完整攻略 2018-12-08
  • 习近平与人民日报那些事 2018-12-07
  • “人工智能创作物”有没有著作权 2018-12-06
  • 营养-热门标签-华商生活 2018-12-06
  • 笑博士,你说说,过去的国民经济发展计划是怎么订立的?有什么样的组织架构具体运作和实现这个事情?笑博士没有那个时代的经历,抄书、抄资料,说成绩、说缺点,都是可以的 2018-12-05
  • 由进口至出口再至走向世界,这一路着实不易,其中少不了无数位科研人员的奉献与牺牲。 2018-12-04
  • [微笑]那就是管理问题了,跟免不免费本身不相干! 2018-12-04
  • 茶马古道:征服世界屋脊的文化之脉 2018-12-03
  • 习近平山东考察,这几个关键词值得深思 2018-12-03
  • 184| 846| 951| 489| 719| 340| 257| 760| 431| 450|